NCT06260943
Targeted Navigation in Hepatocellular Carcinoma (HCC)
At risk: Primary endpoint(s) modified.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 4 more changesShow less
- Study completion pushed from Oct 31, 2026 to Jul 31, 2027
- Primary completion date changed from estimate of Oct 31, 2026 to Oct 15, 2026
- Eligibility criteria expanded, about 14 words
- Secondary endpoints expanded, about 27 words
- Notable Enrollment target: 100 to 210
- Primary endpoints revised (7)
- Minor Site contact updatedv4
- Notable Enrollment target: 50 to 100
- Site contact updated
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of May 31, 2024 to Apr 15, 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of Hours for Each Contact
Timeframe: Up to 12 months
Number of Months of Total Navigation
Timeframe: Up to 12 months
Acceptability
Timeframe: Enrollment
Secondary (4)
Number of Days to First Contact
Number of Participants that Die Within One Year
Number of Days to First Treatment
Proportion of Participants Enrolled in Clinical Research
Arms and interventions
Aim 3: Targeted Navigation Pilot ProgramExperimental
Participants in this group will be enrolled in a Targeted Navigation Pilot Program for up to 12 months.
Behavioral: Target Navigation Pilot Program
Sites
1 site in 1 country
- University of MiamiMiami, Florida, United States